Status:
UNKNOWN
The CMCPCTH Research in Chinese Children
Lead Sponsor:
Shanghai Children's Hospital
Collaborating Sponsors:
Sichuan provincial maternity and child health care hospital
Maternity and Child Health Care Hospital of Pingdingshan City
Conditions:
Tonsillectomy
Child
Eligibility:
All Genders
Up to 18 years
Brief Summary
To obtain hemorrhage rate after coblation tonsillectomy, and to investigate risk factors of hemorrhage after coblation tonsillectomy in children.
Detailed Description
This study is a prospective and multi-centre trail in China. It intends to enroll 25000 patients underwent coblation tonsillectomy in 22 clinical centers in China. Hemorrhage rate and risk factors of ...
Eligibility Criteria
Inclusion
- under 18 years old;
- Clear indications for tonsill surgery;
- No clear contraindications for tonsill surgery;
- Parents of the children patients accept surgical treatment;
- Parents of the children patients able to cooperate with the visit and follow-up.
Exclusion
- Children patients with a history of adenoid or tonsillectomy surgery;
- Associated with refractory bleeding diseases;
- Combined with cleft palate;
- Down syndrome, Prader-Willi syndrome (PWS) or other chromosomal abnormalities;
- Neuromuscular diseases (including cerebral palsy);
- Other diseases that affect physical health, such as severe heart disease, kidney disease, lung disease, etc;
- Contraindications to surgery and anesthesia;
- Unable to obtain informed consent.
Key Trial Info
Start Date :
January 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
25000 Patients enrolled
Trial Details
Trial ID
NCT05206799
Start Date
January 15 2022
End Date
February 28 2024
Last Update
November 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Shanghai
Shanghai, Shanghai Municipality, China, 200062